This announcement is a separate document:
博济医药：北京市康达律师事务所关于广州博济医药生物技术股份有限公司向特定对象发行A股股票的补充法律意见书（二）
Boji Pharmaceutical: Beijing Kangda Law Firm's Supplementary Legal Opinion on Guangzhou Boji Pharmaceutical Biotechnology Co., Ltd.'s Issuance of A-Shares to Specific Targets (2)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated